giichinese.com logo
giichinese.com logo
日商環球訊息有限公司


垂直整合市場
Translational Cancer Medicine
Outsourcing Asia Summit 2009
Global Healthcare Congress 2009
BioMedical Asia 2009
China 2009 Pharmaceutical R&D Summit
Drug Discovery & Development of Innovative Therapeutics Japan 2009
Protein Kinase Targets 2009
Structure-Based Drug Design 2009
World Vaccine Congress Asia 2009
World Pharmaceutical Congress 2009
Drug Discovery & Development of Innovative Therapeutics 2009
- Japanese Korean English
Report
[英文調查報告書]

腦深部電刺激術(DBS)對神經科及精神科藥品市場產生什麼樣的影響?

How Will Deep Brain Stimulation Affect Neurological and Psychiatric Drug Markets?

商品編碼 : 44414
出版日期 : 2006/08

Price

- -
此出版品為英文撰寫

Abstract

Introduction

Deep brain stimulation (DBS) is currently approved only to treat Parkinson's disease and Parkinson-like symptoms; however, clinical trials are under way for DBS in several other neurological and psychiatric disorders. As these surgical interventions gain acceptance in the face of conventional therapies' shortcomings in severely affected patients, opportunities are emerging for such devices, used both alone and in conjunction with existing drug regimens.

Get the Answers You Need to Shape Your Strategy

Currently, DBS is approved only for parkinsonism. For what other indications is DBS being investigated? What advantages does DBS offer to treat these indications? What potential exists for DBS in these indications? The risk factors associated with DBS have made it a last-resort therapy for most indications. How competitive will DBS be with conventional drug therapies? In which indications will it stand out? Will DBS ever be used as an early therapy, in any indication? Medtronic is the only company to have an approved device for DBS, although several companies have devices in development for other indications. Which of the companies developing DBS devices is best positioned to succeed in these new markets? What innovations must these companies provide to ensure success? Which company is poised to collaborate with drugmakers in creating a viable combination therapy?

Table of Contents

  • Executive Summary
  • Strategic Implications
  • Stakeholder Implications
  • Introduction
  • Overview of DBS
  • DBS for Specific Therapeutic Areas
  • Parkinson's Disease
  • Epilepsy
  • Psychiatric Disorders: OCD and Depression
  • Headaches
  • Companies Developing DBS Systems
  • Medtronic
  • NeuroPace
  • Cyberonics
  • Boston Scientific
  • Medtrode
  • Advanced Neuromodulation Systems
  • Impact of DBS on Drug Markets
  • Market Implications
  • DBS and the PD Market
  • DBS and the Epilepsy Market
  • DBS and the Psychiatric Markets
  • DBS and the Headache Market
  • Codevelopment of Pharmacological Agents and DBS
  • Outlook for DBS in the Marketplace
  • Bibliography

Tables

  • 1. Brain Regions Implicated in Epileptic Seizures
  • 2. Companies Developing DBS Devices

Figures

  • 1. Regions of the Brain Targeted for Deep Brain Stimulation
  • 2. Schematic of Deep Brain Stimulation
  • 3. Growth of DBS Procedures, by Indication, 2005-2015
- -
此出版品為英文撰寫

Top

[英文調查報告書]
腦深部電刺激術(DBS)對神經科及精神科藥品市場產生什麼樣的影響?
How Will Deep Brain Stimulation Affect Neurological and Psychiatric Drug Markets?

出版商 : Decision Resources, Inc. Decision Resources, Inc.
代理商 : Global Information, Inc. Global Information, Inc.

US $ 1,112 (PDF by E-mail (Single User License))
商品編碼 : 44414

本頁所標示之售價為不含購買者所在地消費稅之未稅價格,相關消費稅金將另行加至交易金額中